Moberg Pharma AB (publ) has entered into an exclusive licensing agreement with Karo Healthcare AB regarding the commercialization of MOB-015 (Terclara®) in Europe. The agreement comprises 19 European ...
Karo Healthcare AB ("Karo") has entered an exclusive licensing agreement with Moberg Pharma AB ("Moberg Pharma") regarding the commercialisation of MOB-015 in Europe. The agreement comprises 19 ...
Moberg Pharma enters exclusive license agreement with & Karo Healthcare to commercialise MOB-Terclara in Europe: Stockholm Thursday, November 6, 2025, 15:00 Hrs [IST] Moberg Pharm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback